Answers are grounded in this paper and cite their sources.
We report a patient with multifocal motor neuropathy (MMN) who experienced a paradoxical decline in baseline strength to below pretreatment levels during a period of improvement associated with human immunoglobulin (HIG) administration. This outcome suggests that HIG may not limit progression of MMN and may reduce the utility of HIG as chronic therapy.
No takes yet. Share an insight, caveat, or question.
Elliott et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: